{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T12:38:39Z","timestamp":1770813519044,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T00:00:00Z","timestamp":1757894400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Ulm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Res Cardiol"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pulmonary tumor thrombotic microangiopathy (PTTM) is a fatal but treatable condition characterized by the rapid development of pulmonary hypertension (PH) in patients with possibly unknown adenocarcinoma. PTTM is mostly diagnosed post-mortem and considered a rare disease since its acute onset and misdiagnosis provides significant diagnostic and therapeutic challenges.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective analysis of patients who presented with unclear sudden cardiac death and acute right heart failure that had an incidental very recent or unknown malignant cancer, identified eight patients with PTTM and reported the results. Patients were considered from 2009 to 2024 and analyzed at Ulm University Heart Center, Germany with the aim to describe the fatal consequences of unknown acute PTTM with right heart failure and discuss diagnostic and therapeutic strategies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median age was 47\u00a0years (41\u201384\u00a0years); gender was equally distributed. The latest median\u00a0body mass index (BMI) was elevated with 28.4\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      (25\u201336\u00a0kg\/m\n                      <jats:sup>2<\/jats:sup>\n                      ). All patients presented as an emergency and died in our hospital due to right heart failure caused by adenocarcinoma in various locations. Median high-sensitivity troponin T was elevated (42.5 (3\u2013179, normal\u2009&lt;\u200914) ng\/L), median NT-pro-BNP (5375 (3100\u201314,000), normal\u2009&lt;\u2009800 for all age groups, in pg\/mL), and d-dimer values (7.74 (1.1\u201321), normal\u2009&lt;\u20090.5 for patients younger than 50\u00a0years and\u2009&lt;\u20091 for all other age groups, in mg\/FEU) were strongly elevated. Median HbA1c was slightly elevated 7.4% (normal\u2009&lt;\u20096.5%). Median time from last hospital admission to death was 8\u00a0days (1\u201323\u00a0days). At admission, median systolic arterial pressure (sPAP) estimated by echocardiography was 65 (46\u2013115) mmHg. Low NT-proBNP and sPAP values as well as pre-mortem adenocarcinoma diagnosis and (therewith associated) adenocarcinoma-type cancer of unknown primary (CUP) correlated best with longer survival in days (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      and\n                      <jats:italic>r<\/jats:italic>\n                      -values:\u2009\u2212\u20090.88,\u2009\u2212\u20090.76, 0.58, 0.89 respectively). Initiation of specific therapy (chemotherapy or anticoagulation) was correlated with survival (\n                      <jats:italic>\u03c1<\/jats:italic>\n                      \u2009=\u20090.786,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.02).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our data suggest that the combination of elevated hsTnT, NT-proBNP, d-dimer, and HbA1c values in patients with unexplained acute right heart failure may indicate PTTM. Our findings also emphasize the diagnostic challenge posed by PTTM, and imply that targeted therapy, enabled by a timely diagnosis, may improve survival. Therefore, acute and fatal right heart failure in the adult in absence of coronary artery disease, pulmonary embolism, or any other apparent cause, especially in patients with uncontrolled metabolic syndrome, should prompt an urgent diagnostic work-up to rule out unknown cancer with treatable pulmonary tumor embolism, beginning with more extensive imaging (e.g., computed tomography (CT) and magnetic resonance tomography (MRI)), as well as laboratory diagnostics (e.g., tumor markers). In still inconclusive cases, lung biopsy and right heart catheterization should be considered eventually, if possible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphic Abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1007\/s00392-025-02746-w","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T15:20:38Z","timestamp":1757949638000},"page":"495-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Right-sided cardiogenic shock from acute pulmonary tumor thrombotic microangiopathy: a rare but deadly cardio-oncologic and metabolic emergency"],"prefix":"10.1007","volume":"115","author":[{"given":"Stefanie","family":"Andre\u00df","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rima","family":"Melnic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannes","family":"Christow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominik","family":"Buckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp Marcel Jan","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Rottbauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Imhof","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6648-9318","authenticated-orcid":false,"given":"Sascha","family":"d\u2019Almeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,15]]},"reference":[{"issue":"2","key":"2746_CR1","doi-asserted-by":"publisher","DOI":"10.1177\/2045894019851000","volume":"9","author":"RH Godbole","year":"2019","unstructured":"Godbole RH, Saggar R, Kamangar N (2019) Pulmonary tumor thrombotic microangiopathy: a systematic review. Pulm Circ 9(2):2045894019851000. https:\/\/doi.org\/10.1177\/2045894019851000","journal-title":"Pulm Circ"},{"key":"2746_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejro.2020.01.001","volume":"7","author":"H Kamada","year":"2020","unstructured":"Kamada H, Ota H, Terui Y et al (2020) Three cases of pulmonary tumor thrombotic microangiopathy (PTTM): challenge in antemortem diagnosis using lung perfusion blood volume images by dual-energy computed tomography. Eur J Radiol Open 7:100212. https:\/\/doi.org\/10.1016\/j.ejro.2020.01.001","journal-title":"Eur J Radiol Open"},{"issue":"7","key":"2746_CR3","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jaccas.2021.04.013","volume":"3","author":"BP Schwartz","year":"2021","unstructured":"Schwartz BP, Tracy P, Hon S, Farber HW, Udelson JE (2021) Pulmonary tumor thrombotic microangiopathy as a cause of pulmonary hypertension. JACC Case Rep 3(7):1029\u20131031. https:\/\/doi.org\/10.1016\/j.jaccas.2021.04.013","journal-title":"JACC Case Rep"},{"issue":"48","key":"2746_CR4","doi-asserted-by":"publisher","first-page":"6949","DOI":"10.3748\/wjg.v25.i48.6949","volume":"25","author":"S Morita","year":"2019","unstructured":"Morita S, Kamimura K, Abe H et al (2019) Pulmonary tumor thrombotic microangiopathy of hepatocellular carcinoma: a case report and review of literature. World J Gastroenterol 25(48):6949\u20136958. https:\/\/doi.org\/10.3748\/wjg.v25.i48.6949","journal-title":"World J Gastroenterol"},{"key":"2746_CR5","doi-asserted-by":"publisher","DOI":"10.1177\/2050313X20969044","volume":"8","author":"C Burciaga Calderoni","year":"2020","unstructured":"Burciaga Calderoni C, Moretta DT, Merrill-Henry J, Giri PC (2020) Pulmonary tumor thrombotic microangiopathy presenting as recurrent syncope. SAGE Open Med Case Rep 8:2050313X20969044. https:\/\/doi.org\/10.1177\/2050313X20969044","journal-title":"SAGE Open Med Case Rep"},{"issue":"1","key":"2746_CR6","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/1746-1596-6-27","volume":"6","author":"Y Okubo","year":"2011","unstructured":"Okubo Y, Wakayama M, Kitahara K et al (2011) Pulmonary tumor thrombotic microangiopathy induced by gastric carcinoma: morphometric and immunohistochemical analysis of six autopsy cases. Diagn Pathol 6(1):27. https:\/\/doi.org\/10.1186\/1746-1596-6-27","journal-title":"Diagn Pathol"},{"issue":"3","key":"2746_CR7","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/1097-0142(19900801)66:3<587::aid-cncr2820660330>3.0.co;2-j","volume":"66","author":"A von Herbay","year":"1990","unstructured":"von Herbay A, Illes A, Waldherr R, Otto HF (1990) Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 66(3):587\u2013592. https:\/\/doi.org\/10.1002\/1097-0142(19900801)66:3%3c587::aid-cncr2820660330%3e3.0.co;2-j","journal-title":"Cancer"},{"issue":"5","key":"2746_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1200\/JCO.2006.09.0670","volume":"25","author":"S Miyano","year":"2007","unstructured":"Miyano S, Izumi S, Takeda Y et al (2007) Pulmonary tumor thrombotic microangiopathy. J Clin Oncol 25(5):597\u2013599. https:\/\/doi.org\/10.1200\/JCO.2006.09.0670","journal-title":"J Clin Oncol"},{"key":"2746_CR9","unstructured":"https:\/\/leitlinien.dgk.org\/files\/12_2022_pocket_leitlinien_pulmonale_hypertonie_korrigiert.pdf"},{"issue":"8","key":"2746_CR10","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1158\/0008-5472.CAN-17-3043","volume":"78","author":"Y Park","year":"2018","unstructured":"Park Y, Peterson LL, Colditz GA (2018) The plausibility of obesity paradox in cancer-point. Cancer Res 78(8):1898\u20131903. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-3043","journal-title":"Cancer Res"},{"issue":"1","key":"2746_CR11","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1158\/jcr.1925.148","volume":"9","author":"O Warburg","year":"1925","unstructured":"Warburg O (1925) The metabolism of carcinoma cells. J Cancer Res 9(1):148\u2013163","journal-title":"J Cancer Res"},{"issue":"3","key":"2746_CR12","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.tibs.2015.12.001","volume":"41","author":"MV Liberti","year":"2016","unstructured":"Liberti MV, Locasale JW (2016) The warburg effect: how does it benefit cancer cells? Trends Biochem Sci 41(3):211\u2013218. https:\/\/doi.org\/10.1016\/j.tibs.2015.12.001","journal-title":"Trends Biochem Sci"},{"issue":"1","key":"2746_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1200\/JCO.2009.27.3011","volume":"29","author":"KS Peairs","year":"2011","unstructured":"Peairs KS, Barone BB, Snyder CF et al (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and meta-analysis. J Clin Oncol 29(1):40\u201346. https:\/\/doi.org\/10.1200\/JCO.2009.27.3011","journal-title":"J Clin Oncol"},{"issue":"4","key":"2746_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.3322\/caac.20078","volume":"60","author":"E Giovannucci","year":"2010","unstructured":"Giovannucci E, Harlan DM, Archer MC et al (2010) Diabetes and cancer: a consensus report. CA Cancer J Clin 60(4):207\u2013221. https:\/\/doi.org\/10.3322\/caac.20078","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"2746_CR15","doi-asserted-by":"publisher","first-page":"11844","DOI":"10.1038\/s41598-023-38431-z","volume":"13","author":"Y Chen","year":"2023","unstructured":"Chen Y, Mushashi F, Son S, Bhatti P, Dummer T, Murphy RA (2023) Diabetes medications and cancer risk associations: a systematic review and meta-analysis of evidence over the past 10 years. Sci Rep 13(1):11844. https:\/\/doi.org\/10.1038\/s41598-023-38431-z","journal-title":"Sci Rep"},{"issue":"1","key":"2746_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.4103\/2045-8932.109910","volume":"3","author":"PR Forfia","year":"2013","unstructured":"Forfia PR, Vaidya A, Wiegers SE (2013) Pulmonary heart disease: the heart-lung interaction and its impact on patient phenotypes. Pulm Circ 3(1):5\u201319. https:\/\/doi.org\/10.4103\/2045-8932.109910","journal-title":"Pulm Circ"},{"issue":"8","key":"2746_CR17","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1161\/01.cir.102.8.865","volume":"102","author":"N Nagaya","year":"2000","unstructured":"Nagaya N, Nishikimi T, Uematsu M et al (2000) Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 102(8):865\u2013870. https:\/\/doi.org\/10.1161\/01.cir.102.8.865","journal-title":"Circulation"},{"key":"2746_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106685","volume":"190","author":"MVF Garcia","year":"2021","unstructured":"Garcia MVF, Souza R, Costa ELV, Fernandes CJCS, Jardim CVP, Caruso P (2021) Outcomes and prognostic factors of decompensated pulmonary hypertension in the intensive care unit. Respir Med 190:106685. https:\/\/doi.org\/10.1016\/j.rmed.2021.106685","journal-title":"Respir Med"},{"issue":"5","key":"2746_CR19","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/1358863X221109855","volume":"27","author":"G Chi","year":"2022","unstructured":"Chi G, Lee JJ, Memar Montazerin S, Marszalek J (2022) Association of D-dimer with short-term risk of venous thromboembolism in acutely ill medical patients: a systematic review and meta-analysis. Vasc Med 27(5):478\u2013486. https:\/\/doi.org\/10.1177\/1358863X221109855","journal-title":"Vasc Med"},{"issue":"3","key":"2746_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/jth.12498","volume":"12","author":"G Lerstad","year":"2014","unstructured":"Lerstad G, Brodin EE, Enga KF, Schirmer H, Nj\u00f8lstad I, Svartberg J, Braekkan SK, Hansen J-B (2014) Hyperglycemia, assessed according to HbA1c, and future risk of venous thromboembolism: the Troms\u00f8 study. J Thromb Haemost 12(3):313\u2013319. https:\/\/doi.org\/10.1111\/jth.12498","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2746_CR21","doi-asserted-by":"publisher","first-page":"2495","DOI":"10.1038\/s41598-020-59173-2","volume":"10","author":"A Mathis","year":"2020","unstructured":"Mathis A, Villiger L, Reiner MF, Egloff M, Schmid HR, Stivala S, Limacher A, Mean M, Aujesky D, Rodondi N, Angelillo-Scherrer A, Righini M, Staub D, Aschwanden M, Frauchiger B, Osterwalder J, Kucher N, Matter CM, Banyai M, Hugli O, Beer JH (2020) Elevated HbA1c is not associated with recurrent venous thromboembolism in the elderly, but with all-cause mortality- the SWEETCO 65+ study. Sci Rep 10(1):2495. https:\/\/doi.org\/10.1038\/s41598-020-59173-2","journal-title":"Sci Rep"},{"key":"2746_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01432-1","volume":"21","author":"SHR Charlier","year":"2022","unstructured":"Charlier SHR, Meier C, Jick SS, Meier CR (2022) Association between glycemic control and risk of venous thromboembolism in diabetic patients: a nested case\u2013control study. Cardiovasc Diabetol 21:2. https:\/\/doi.org\/10.1186\/s12933-021-01432-1","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2746_CR23","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa0908359","volume":"362","author":"E Selvin","year":"2010","unstructured":"Selvin E, Steffes MW, Zhu H et al (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362(9):800\u2013811. https:\/\/doi.org\/10.1056\/NEJMoa0908359","journal-title":"N Engl J Med"},{"issue":"1","key":"2746_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3390\/biom5010194","volume":"5","author":"K Nowotny","year":"2015","unstructured":"Nowotny K, Jung T, H\u00f6hn A, Weber D, Grune T (2015) Advanced glycation end products and oxidative stress in type 2 diabetes mellitus. Biomolecules 5(1):194\u2013222. https:\/\/doi.org\/10.3390\/biom5010194","journal-title":"Biomolecules"},{"issue":"12","key":"2746_CR25","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1002\/clc.23900","volume":"45","author":"W Song","year":"2022","unstructured":"Song W, Zhu J, Zhong Z, Song Y, Liu S (2022) Long-term outcome prediction for chronic thromboembolic pulmonary hypertension after pulmonary endarterectomy. Clin Cardiol 45(12):1255\u20131263. https:\/\/doi.org\/10.1002\/clc.23900","journal-title":"Clin Cardiol"},{"issue":"1","key":"2746_CR26","doi-asserted-by":"publisher","first-page":"6490","DOI":"10.1038\/s41598-023-33727-6","volume":"13","author":"H Tsubata","year":"2023","unstructured":"Tsubata H, Nakanishi N, Itatani K, Takigami M, Matsubara Y, Ogo T, Fukuda T, Matsuda H, Matoba S (2023) Pulmonary artery blood flow dynamics in chronic thromboembolic pulmonary hypertension. Sci Rep 13(1):6490. https:\/\/doi.org\/10.1038\/s41598-023-33727-6","journal-title":"Sci Rep"},{"key":"2746_CR27","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ijcha.2017.09.001","volume":"17","author":"H Chibana","year":"2017","unstructured":"Chibana H, Tahara N, Itaya N, Ishimatsu T, Sasaki M, Sasaki M, Nakayoshi T, Ohtsuka M, Yokoyama S, Sasaki KI, Ueno T, Fukumoto Y (2017) Pulmonary artery dysfunction in chronic thromboembolic pulmonary hypertension. IJC Heart Vasc 17:30\u201332. https:\/\/doi.org\/10.1016\/j.ijcha.2017.09.001","journal-title":"IJC Heart Vasc"},{"key":"2746_CR28","doi-asserted-by":"publisher","first-page":"2402268","DOI":"10.1183\/13993003.02268-2024","volume":"66","author":"T Kiko","year":"2025","unstructured":"Kiko T, Asano R, Yoshikawa Y, Endo H, Fujisaki S, Takano R, Akao M, Nishi N, Hayashi H, Ogata S, Kotoku A, Horinouchi H, Inoue Y, Ueda J, Seike Y, Tsuji A, Fukuda T, Nishimura K, Matsuda H, Ogo T (2025) Survival trends in patients with chronic thromboembolic pulmonary hypertension: an observational study. Eur Respir J 66:2402268. https:\/\/doi.org\/10.1183\/13993003.02268-2024","journal-title":"Eur Respir J"},{"issue":"22","key":"2746_CR29","doi-asserted-by":"publisher","first-page":"2595","DOI":"10.2169\/internalmedicine.53.2379","volume":"53","author":"K Higo","year":"2014","unstructured":"Higo K, Kubota K, Takeda A, Higashi M, Ohishi M (2014) Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med 53(22):2595\u20132599. https:\/\/doi.org\/10.2169\/internalmedicine.53.2379","journal-title":"Intern Med"},{"issue":"2","key":"2746_CR30","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1536\/ihj.14-220","volume":"56","author":"S Minatsuki","year":"2015","unstructured":"Minatsuki S, Miura I, Yao A et al (2015) Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy. Int Heart J 56(2):245\u2013248. https:\/\/doi.org\/10.1536\/ihj.14-220","journal-title":"Int Heart J"},{"issue":"19","key":"2746_CR31","doi-asserted-by":"publisher","first-page":"2767","DOI":"10.2169\/internalmedicine.51.7682","volume":"51","author":"H Kayatani","year":"2012","unstructured":"Kayatani H, Matsuo K, Ueda Y et al (2012) Pulmonary tumor thrombotic microangiopathy diagnosed antemortem and treated with combination chemotherapy. Intern Med 51(19):2767\u20132770. https:\/\/doi.org\/10.2169\/internalmedicine.51.7682","journal-title":"Intern Med"},{"issue":"1","key":"2746_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-023-00477-4","volume":"21","author":"Y Wang","year":"2023","unstructured":"Wang Y, Ning WW, Jin YF et al (2023) Anlotinib dramatically improved pulmonary hypertension and hypoxia caused by pulmonary tumor thrombotic microangiopathy (PTTM) associated with gastric carcinoma: a case report. Thromb J 21(1):33. https:\/\/doi.org\/10.1186\/s12959-023-00477-4","journal-title":"Thromb J"},{"issue":"3","key":"2746_CR33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/0167-5273(93)90040-n","volume":"39","author":"JS Bhuvaneswaran","year":"1993","unstructured":"Bhuvaneswaran JS, Venkitachalam CG, Sandhyamani S (1993) Pulmonary wedge aspiration cytology in the diagnosis of recurrent tumour embolism causing pulmonary arterial hypertension. Int J Cardiol 39(3):209\u2013212. https:\/\/doi.org\/10.1016\/0167-5273(93)90040-n","journal-title":"Int J Cardiol"}],"container-title":["Clinical Research in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02746-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00392-025-02746-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00392-025-02746-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T07:58:20Z","timestamp":1770796700000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00392-025-02746-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,15]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["2746"],"URL":"https:\/\/doi.org\/10.1007\/s00392-025-02746-w","relation":{},"ISSN":["1861-0684","1861-0692"],"issn-type":[{"value":"1861-0684","type":"print"},{"value":"1861-0692","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,15]]},"assertion":[{"value":"25 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study conforms to the guidelines of the Declaration of Helsinki, adheres to the STROBE statement and was approved by the local ethics committee (ethics application number University Ulm, Head: Prof Dr. Steger. The study does not involve the specific use or collection of any animal or human tissue.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}